
Press Release|Articles|March 8, 2024
Camber Pharmaceuticals Launches Generic Vascepa®
Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.
Advertisement
Camber Pharmaceuticals is pleased to announce the addition of Icoapent Ethyl Capsules to its current portfolio.
Icosapent Ethyl Capsules are an ethyl ester of eicosapentaenoic acid (EPA) indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.
Icosapent Ethyl Capsules are available in:
- 0.5 gram - 240 count bottles
- 1 gram - 120 count bottles
To find out more about Icosapent Ethyl Capsule, please visit
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
FDA Expands Accelerated Approval of Sevabertinib to First-Line HER2-Mutant NSCLC
3
In-Hospital Dapagliflozin Speeds Decongestion in Heart Failure
4
Tozorakimab Reduces COPD Exacerbations Across Eosinophil Levels in Phase 3 Trials
5




































































































